drugset / Trial / NCT00380133
Study of SB681323 and Prednisolone on Biomarkers in COPD (Chronic Obstructive Pulmonary Disease) Patients
RandomizedCrossoverDouble-blindTreatment
Summary
This study will assess the effects of single oral doses of SB681323 and prednisolone on biomarkers in induced sputum and blood COPD patients
Timeline
- Start
- 2005-06
- Primary completion
- 2006-04
- Completion
- 2006-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Prednisolone | Other / unclassified | 10 mg | Oral |
| Subject | Prednisolone | Other / unclassified | 30 mg | Oral |
| Subject | dilmapimod | Small molecule | 7.5 mg | Oral |
| Subject | dilmapimod | Small molecule | 25 mg | Oral |